<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
48462-001-02
</NDCCode>
<PackageDescription>
13310 BOTTLE, DROPPER in 1 CARTON (48462-001-02) > 13310 mg in 1 BOTTLE, DROPPER (48462-001-01)
</PackageDescription>
<NDC11Code>
48462-0001-02
</NDC11Code>
<ProductNDC>
48462-001
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Nafasolina
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Naphazoline Hydrochloride
</NonProprietaryName>
<DosageFormName>
SOLUTION/ DROPS
</DosageFormName>
<RouteName>
NASAL
</RouteName>
<StartMarketingDate>
20210215
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
OTC MONOGRAPH FINAL
</MarketingCategoryName>
<ApplicationNumber>
part341
</ApplicationNumber>
<LabelerName>
DUY DRUGS, INC
</LabelerName>
<SubstanceName>
NAPHAZOLINE HYDROCHLORIDE
</SubstanceName>
<StrengthNumber>
.376
</StrengthNumber>
<StrengthUnit>
mg/100mg
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2023-01-03
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20221231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20210215
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>